Choroidal thickness in geographic atrophy secondary to age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 2, 2015, Pages 875-882

  Lindner, Moritz ^a   Bezatis, Athanasios ^a   Czauderna, Joanna ^a   Becker, Eva ^a   Brinkmann, Christian K ^a   Schmitz Valckenberg, Steffen ^a   Fimmers, Rolf ^a   Holz, Frank G ^a   Fleckenstein, Monika ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Choroidal thickness; Fundus autofluorescence; Geographic atrophy

Indexed keywords

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; ATROPHY SIZE; AUTOFLUORESCENCE IMAGING; CHOROIDAL THICKNESS; CONFOCAL SCANNING LASER OPHTHALMOSCOPY; CONTROLLED STUDY; ENHANCED DEPTH IMAGING; EYE FUNDUS; FEMALE; GEOGRAPHIC ATROPHY; HUMAN; IMAGING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA FOVEA; SCANNING LASER OPHTHALMOSCOPY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL SYSTEM PARAMETERS; CHOROID; COMPLICATION; DISEASE COURSE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; MACULAR DEGENERATION; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; VISUAL ACUITY;

AGED; CHOROID; DISEASE PROGRESSION; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; GEOGRAPHIC ATROPHY; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84922570574     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14933     Document Type: Article

References (45)

1. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology. 2002;109:1767–1779.
2. Friedman DS, O’Colmain BJ, Munoz B, et al. Prevalence of age related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–572.
3. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116:653–658.
4. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of agerelated maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995;102:1450–1460.
5. Ferris FL 3rd, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640–1642.
6. Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren Campagne M. Geographic atrophy: Clinical features and potential therapeutic approaches. Ophthalmology. 2014;121: 1079-1091.
7. Green WR, Key SN 3rd. Senile macular degeneration: A histopathologic study. Trans Am Ophthalmol Soc. 1977;75: 180–254.
8. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond). 1988;2: 552–577.
9. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496–500.
10. Mrejen S, Spaide RF. Optical coherence tomography: Imaging of the choroid and beyond. Surv Ophthalmol. 2013;58:387–429.
11. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147:811–815.
12. Chung SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology. 2011;118:840–845.
13. Kim SW, Oh J, Kwon SS, Yoo J, Huh K. Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy. Retina. 2011;31:1904–1911.
14. Koizumi H, Yamagishi T, Yamazaki T, Kawasaki R, Kinoshita S. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graef’s Arch Clin Exp Ophthalmol. 2011;249:1123–1128.
15. Manjunath V, Goren J, Fujimoto JG, Duker JS. Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography. Am J Ophthalmol. 2011;152:663–668.
16. Wood A, Binns A, Margrain T, et al. Retinal and choroidal thickness in early age-related macular degeneration. Am J Ophthalmol. 2011;152:1030–1038.
17. Jirarattanasopa P, Ooto S, Nakata I, et al. Choroidal thickness, vascular hyperpermeability, and complement factor H in agerelated macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2012;53:3663–3672.
18. Noori J, Riazi Esfahani M, Hajizadeh F, Zaferani MM. Choroidal mapping; a novel approach for evaluating choroidal thickness and volume. J Ophthalmic Vis Res. 2012;7:180–185.
19. Adhi M, Lau M, Liang MC, Waheed NK, Duker JS. Analysis of the thickness and vascular layers of the choroid in eyes with geographic atrophy using spectral-domain optical coherence tomography. Retina. 2014;34:306–312.
20. Coscas F, Puche N, Coscas G, et al. Comparison of macular choroidal thickness in adult onset foveomacular vitelliform dystrophy and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014;55:64–69.
21. Jonas JB, Forster TM, Steinmetz P, Schlichtenbrede FC, Harder BC. Choroidal thickness in age-related macular degeneration. Retina. 2014;34:1149–1155.
22. Lee JY, Lee DH, Yoon YH. Correlation between subfoveal choroidal thickness and the severity or progression of nonexudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013;54:7812–7818.
23. Sigler EJ, Randolph JC. Comparison of macular choroidal thickness among patients older than age 65 with early atrophic age-related macular degeneration and normals. Invest Ophthalmol Vis Sci. 2013;54:6307–6313.
24. Kang HM, Kwon HJ, Yi JH, Lee CS, Lee SC. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration. Am J Ophthalmol. 2014;157:1013–1021.
25. Holz FG, Bindewald-Wittich A, Fleckenstein M, Dreyhaupt J, Scholl HP, Schmitz-Valckenberg S. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol. 2007; 143:463–472.
26. Bindewald A, Schmitz-Valckenberg S, Jorzik JJ, et al. Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration. Br J Ophthalmol. 2005;89:874–878.
27. Fleckenstein M, Schmitz-Valckenberg S, Lindner M, et al. The ‘‘diffuse-trickling’’ fundus autofluorescence phenotype in geographic atrophy. Invest Ophthalmol Vis Sci. 2014;55: 2911–2920.
28. Fleckenstein M, Schmitz-Valckenberg S, Martens C, et al. Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy. Invest Ophthalmol Vis Sci. 2011;52: 3761–3766.
29. Ramrattan RS, van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, de Jong PT. Morphometric analysis of Bruch’s membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci. 1994;35:2857–2864.
30. Spraul CW, Lang GE, Grossniklaus HE, Lang GK. Histologic and morphometric analysis of the choroid, Bruch’s membrane, and retinal pigment epithelium in postmortem eyes with agerelated macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol. 1999;44(suppl 1):S10–S32.
31. Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010;29:144–168.
32. Spaide RF. Age-related choroidal atrophy. Am J Ophthalmol. 2009;147:801–810.
33. Tan CS, Ouyang Y, Ruiz H, Sadda SR. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53:261–266.
34. Vance SK, Imamura Y, Freund KB. The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina. 2011; 31:332–335.
35. Brown JS, Flitcroft DI, Ying GS, et al. In vivo human choroidal thickness measurements: evidence for diurnal fluctuations. Invest Ophthalmol Vis Sci. 2009;50:5–12.
36. Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol. 2009;148: 445–450.
37. Wei WB, Xu L, Jonas JB, et al. Subfoveal choroidal thickness: The Beijing Eye Study. Ophthalmology. 2013;120:175–180.
38. Mansouri K, Medeiros FA, Marchase N, Tatham AJ, Auerbach D, Weinreb RN. Assessment of choroidal thickness and volume during the water drinking test by swept-source optical coherence tomography. Ophthalmology. 2013;120:2508–2516.
39. Vural AD, Kara N, Sayin N, Pirhan D, Ersan HB. Choroidal thickness changes after a single administration of coffee in healthy subjects. Retina. 2014;34:1223–1228.
40. Zengin MO, Cinar E, Kucukerdonmez C. The effect of nicotine on choroidal thickness. Br J Ophthalmol. 2014;98:233–237.
41. Johnstone J, Fazio M, Rojananuangnit K, et al. Variation of the axial location of Bruch’s membrane opening with age, choroidal thickness, and race. Invest Ophthalmol Vis Sci. 2014;55:2004–2009.
42. Li XQ, Larsen M, Munch IC. Subfoveal choroidal thickness in relation to sex and axial length in 93 Danish university students. Invest Ophthalmol Vis Sci. 2011;52:8438–8441.
43. Sohrab M, Wu K, Fawzi AA. A pilot study of morphometric analysis of choroidal vasculature in vivo, using en face optical coherence tomography. PloS One. 2012;7:e48631.
44. Usui S, Ikuno Y, Akiba M, et al. Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. Invest Ophthalmol Vis Sci. 2012; 53:2300–2307.
45. Kur J, Newman EA, Chan-Ling T. Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog Retin Eye Res. 2012; 31:377–406.